HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.790
+0.350 (10.17%)
At close: Sep 16, 2026, 4:00 PM EDT
3.900
+0.110 (2.90%)
After-hours: Sep 16, 2026, 6:27 PM EDT
HeartSciences Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Cash & Equivalents | 0.03 | 1.66 | 1.1 | 5.81 | 1.66 | 0.92 |
Cash & Short-Term Investments | 0.03 | 1.66 | 1.1 | 5.81 | 1.66 | 0.92 |
Cash Growth | -98.93% | 50.88% | -81.09% | 249.76% | 80.83% | 26.92% |
Receivables | - | - | 0 | - | - | 0 |
Inventory | 0.4 | 0.66 | 0.65 | 0.63 | 0.68 | 0.67 |
Prepaid Expenses | 0.21 | 0.08 | 0.09 | 0.18 | 0.14 | 0.05 |
Other Current Assets | 0.17 | 0.19 | 0.33 | 0.73 | 0.22 | 0.29 |
Total Current Assets | 0.81 | 2.58 | 2.17 | 7.35 | 2.7 | 1.93 |
Property, Plant & Equipment | 0.27 | 0.31 | 0.44 | 0.56 | 0.59 | 0.16 |
Other Intangible Assets | 2.65 | 2.37 | 1.62 | 1.59 | - | - |
Total Assets | 3.74 | 5.26 | 4.22 | 9.5 | 3.29 | 2.09 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Accounts Payable | 1.02 | 0.32 | 0.32 | 0.45 | 0.63 | 0.69 |
Accrued Expenses | 0.56 | 0.76 | 0.68 | 0.67 | 0.62 | 1.05 |
Current Portion of Long-Term Debt | 3.72 | 3.62 | 2.55 | 0.5 | 0.5 | 1.63 |
Current Portion of Leases | 0.14 | 0.14 | 0.12 | 0.1 | 0.03 | 0.09 |
Other Current Liabilities | 0.18 | 0.02 | 0.03 | 0.03 | 0.05 | 0 |
Total Current Liabilities | 5.63 | 4.86 | 3.7 | 1.75 | 1.83 | 3.47 |
Long-Term Debt | - | - | - | - | 0.5 | 4.44 |
Long-Term Leases | 0.14 | 0.18 | 0.31 | 0.43 | 0.54 | - |
Other Long-Term Liabilities | - | - | - | - | 0.19 | 0.23 |
Total Liabilities | 5.77 | 5.04 | 4.02 | 2.19 | 3.06 | 8.15 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 86.4 | 85.49 | 76.33 | 74.68 | 60.99 | 48.34 |
Retained Earnings | -88.44 | -85.27 | -76.13 | -67.36 | -60.76 | -54.4 |
Total Common Equity | -2.03 | 0.23 | 0.2 | 7.32 | 0.23 | -6.06 |
Shareholders' Equity | -2.03 | 0.23 | 0.21 | 7.32 | 0.23 | -6.06 |
Total Liabilities & Equity | 3.74 | 5.26 | 4.22 | 9.5 | 3.29 | 2.09 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Total Debt | 4 | 3.94 | 2.99 | 1.04 | 1.57 | 6.16 |
Net Cash (Debt) | -3.97 | -2.28 | -1.89 | 4.77 | 0.09 | -5.24 |
Net Cash Growth | - | - | - | 4943.83% | - | - |
Net Cash Per Share | -1.24 | -0.87 | -2.01 | 13.53 | 1.19 | -158.02 |
Filing Date Shares Outstanding | 4.8 | 3.9 | 1.93 | 0.86 | 0.1 | 0.08 |
Total Common Shares Outstanding | 3.9 | 3.19 | 1.12 | 0.68 | 0.1 | 0.03 |
Working Capital | -4.82 | -2.28 | -1.53 | 5.6 | 0.86 | -1.54 |
Book Value Per Share | -0.52 | 0.07 | 0.18 | 10.81 | 2.27 | -182.20 |
Tangible Book Value | -4.69 | -2.15 | -1.41 | 5.73 | 0.23 | -6.06 |
Tangible Book Value Per Share | -1.20 | -0.67 | -1.26 | 8.47 | 2.27 | -182.20 |
Machinery | - | 0.57 | 0.57 | 0.56 | 0.5 | 0.48 |
Leasehold Improvements | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |